NathalieAusch
Associate
Nathalie is an investment professional with a background in healthcare strategy consulting. Prior to GHO, she worked at Oliver Wyman in London as part of the Health and Life Sciences team, where she conducted commercial strategy, due diligence, and operations strategy projects for clients across a broad spectrum of healthcare verticals. Before consulting, Nathalie also gained experience in biotech equity research and early-stage biotech venture capital.
Nathalie holds a Masters in Bioscience Enterprise from the University of Cambridge and a BSc in Biochemistry from Imperial College London. She is a German native speaker and fluent in English.